Derek Yung
Analyst · Credit Suisse. Your line is now open
Thank you, Scott, and good afternoon, everyone. Our third quarter results reflect strong revenue and enrollment growth in our Medicare and Individual and Family businesses and a significant investment in our telesales capacity and marketing initiatives ahead of the Medicare annual enrollment period. In our Medicare business third quarter revenue of 57.2 million grew 75%, compared to a year ago, due to a 70% year-over-year increase in approved Medicare members, 64% growth in non-commissioned revenue driven primarily by carriers sponsorship revenue, and 3.8 million in tele revenue, driven by greater than estimated customer policy fruition, which I will describe in greater detail shortly. The Medicare segments generated a lot of 11 million, reflecting investments as we have prepared for what is expected to be another record fourth quarter selling season in terms of revenue, enrollment volumes and profitability. Year-to-date, our Medicare segments profit was 5.9 million compared to 2.2 million for the same period last year. Our estimated number of revenue generating Medicare members was approximately $551,000 at the end of the third quarter, up from approximately 410,000 at the end of the third quarter of 2018 or an increase of 34%. Third quarter 2019 revenue from our individual family and small business segments was12.7 million, a 59 increase compared to a year ago. Similar to second quarter, we saw a strong increase in the number of approved members for major medical ISP products, which grew at 76% year-over-year. In addition, we are seeing a continue trend of longer durations of these products, resulting in higher estimated lifetime value. Third quarter constrained LTVs for Individual and Family plan products grew an excess of 40% compared to the third quarter year ago as a result of favorable commission rate and policy duration. Commissioned revenue in our IP business grew 95% compared to a year ago, small business group commission revenue increased by 14% year-over-year. The individual family and small business segment profit was 3.8 million compared to a loss of 0.6 million in the third quarter of 2018. Our estimated Individual and Family plan membership at the end of third quarter was approximately 131,000 down 19% compared to the estimated membership of 161,000 we reported at the end of third quarter a year ago. The estimated number of members on small business projects with approximately 45,000 a 17% increase compared to a year ago. Our total revenue for the third quarter was 69.9 million, an increase of 72% compared to third quarter of 2018. Our total estimated membership at the end of the quarter for all products combined was approximately 991,000 members including approximately $264 estimated members on ancillary product. Before I move on to discuss the operating expenses, I will provide more detail on the dynamics that we're seeing with estimated lifetime values or LTVs in our Medicare business. Under ASC 606 accounting, we recognized revenue based on the constrained lifetime value of each moment that is approved by our carrier partners. The base LTV are determined for an estimation of commission payments that we expect to collect over the life of approved business and it's based on a detailed historical analysis of several input including our past experience with policy duration in commission rate per paying member. These estimates of debate LTV are then reduced by applying constraints factor effectively discounting the revenue we book compared to what we expect to collect. Just constraints active insurance against overstaying revenue for the duration of the policy due to fluctuations in policy duration, commissioned rates or other external factors. Our revenue recognition approach using constraint LTVs is appropriately conservative and this is demonstrated and how we recognize tail revenue in every quarter of 2019. We recognized tele revenue when we're cash collections are in excess of the estimated constraint LTVs for previously sold Medicare policy. The constrained LTVs for Medicare Advantage plan, which complement majority of our existing Medicare members have grown on a year-over-year basis for five consecutive quarters, driven by higher commission rates and better than expected policy duration on many of our existing policies. On our last earnings call in July, we noted that several, after several quarters of continuous growth and constrained LTVs for Medicare Advantage products, we expected that the LTV to decline by mid-single digit for pre application in the fourth quarter of 2019 compared to the fourth quarter of 2018. This forecast was driven by higher-policy turnover that we observe during the first quarter this year on Medicare Advantage members that we enrolled during the last annual enrollment period in the fourth quarter of 2018. We believe that the increased turnover in that specific group of approved application was driven by the open enrollment period which took place in the first quarter of this year for the first time since 2011. Since our earnings call in July, we have observed a reversal of the trend with lower turnover under the Medicare Advantage cohort. As a result, the difference between cumulative turn over on this Medicare Advantage cohort on a year to date basis compared to how prior cohorts turnover by this time has narrowed. At this point in the light of these circumstances we expect that fourth quarter Medicare Advantage constrained LTVs will only be down by one to two percentage points compared to the Medicare Advantage constrain LTV for the fourth quarter of 2018. For the full year 2019 our weighted average Medicare Advantage LTVs are expected to be flat to slightly up compared to 2018. Our commission receivable balance at the end of third quarter was 358 million, an increase of 16 million compared to the ending balance at the end of the second quarter and an increase of 92 million compared to the balance at the end of the third quarter a year ago. Our commission receivable balance reflects future commissions we expect to collect on our existing membership discounted by the constraint factor that I described earlier. Our commission receivable balances increased as each quarter by the amount that we recognized our revenue for in quarter enrollment, which is based on lifetime value estimates. This increase is net of the upfront commission payments for any quarter enrollment and reoccurring commission payment that were received on our existing members enrolled in prior periods. During the third quarter, we collected 43.4 million in commission payments. Now, I would like to review operating expenses and profitability metrics. In the third quarter, we made significant investments in expanding on Medicare telesales capacity including our new Indianapolis sales and their launch as well as hiring, training, and on-boarding agents ahead of the October 15th start to AEP. As Scott mentioned earlier on the call, we grew our agent count in excess of 100% compared to the same time a year ago through a combination of in house hiring expanding our outsourced agent force. Our third quarter non-GAAP customer care enrollment expenses which exclude stock-based compensation grew 22.7 million or 133% compared to a third quarter a year ago. Reflecting this investment as well as the fact that we are operating with a larger agent count throughout this year haven't kept the majority of our in-house agents on-board following the completion of the last AEP. The nearly hired agents were not fully productive for most of the third quarter as they were going through licensing and training. As a result, customer care enrollment expense per approved member increased significantly both sequentially and on a year-over-year basis. Similar to last year, we expect this metric to come down in the fourth quarter when our expanded telesales resources are averaged across a much larger volume of enrollments and that the agents become more productive. Our non-GAAP marketing and advertising expense which excludes stock-based compensation grew 9.3 million or 60% year-over-year. Variable marketing expense in our Medicare business grew 78% comparison to 70% growth in approved Medicare members, as we invested more on the margin in direct online demand generation channels that have higher marketing costs of acquisition, but also tend to have higher on the online conversions. Shifting towards increased online penetration which should overtime translate into your higher operations scalability and lower agent cost per enrollment is at the core of our growth strategy in the Medicare market. Adjusted EBITDA for the third quarter of 2019 was negative 18.8 million, which was better than our expectations in compared to negative 6.9 million for the third quarter of 2018. We calculate an adjusted EBITDA by adding restructuring charges, acquisition costs, stock-based compensation, change in fair value of earn out liability, depreciation and amortization, amortization of requiring tangible, other income and benefit from income taxes to our GAAP net loss. GAAP net loss for the third quarter of 2019 was 11 million, compared to GAAP net loss of 9 million for the third quarter of 2018. Our third quarter cash flow from operations was negative 15.9 million, compared to a negative 5 million for the third quarter 2018. Capital expenditures, which include capitalized internal developed software costs were approximately 4 million for the third quarter. Our cash balance was 91.4 million as of September 30th. And we had no debt outstanding under our line of credit. Based on information available as of October 24, 2019, eHealth is reaffirming his guidance for total revenue and adjusted EBITDA for the full year ending December 31, 2019. And also updating this guidance for certain GAAP and non-GAAP measures for the full year ending December 31, 2019, due to the third quarter of 2019 reduction in fair value of the earner liability assuming connection with our acquisition of GoMedigap and a change in income tax rate. Our 2019 guidance ranges are included in our third quarter earnings release for your reference Based on the quality and scalable call center resources in place to acceleration of online enrollments and the strength of our consumer demand were observing. We are confident and our ability to deliver at the high end of the revenue and EBITDA guidance ranges. This implies a year-over-year growth in 2019 approved Medicare members of over 60%. Afterwards has been investment quarter we are forecasting a return to meaningful EBITDA profitability in the fourth quarter, driven by significant sequential increase in enrollment growth and a related increase in our revenue. On a year-over-year basis, we forecast our fourth quarterly results to grow significantly those on a margin and absolute dollar basis relative to fourth quarter of 2018. The top end of our 2019 EBITDA guidance implies fourth quarter 2019 EBITDA growth of 50% compared to Q4 of 2018. I want to remind you that these comments and our guidance are based on current indications of our business and our current estimates, assumptions and judgments, which may change at any time. Our actual results may differ as a result of changes in our estimate assumptions and judgments. We undertake no obligation to update our comments or our guidance. Before we turn the call over to the operator I want to address our membership metrics in context of customer retention, a topic that's been top of investors and analysts over the past few months. In order to compute customer calls retention rate it's important to keep in mind the following dynamic. One, our retention rates are more accurately assessed by using the number of paying members that we add in a given period, and not the number in period approved members. Our approved Medicare Advantage members have converted into paying at an average of 92%. In addition, some of the members that are proved any given quarter don't become paying members until the following quarter, a spillover effect especially pronounced during high enrollment quarters. Second, policy turnover is higher in the first year post approval and start to decline in and out of years. Policy persistency is particularly strong; one policy has been help year-over-year getting us to our current average policy duration of approximately three years for Medicare Advantage. Three and lastly, due to pronounced seasonality of our enrollments it is more accurate to look at churn and other metrics on trailing 12 month basis. We summarize these points and also provide an example of customer policy retention map as part of operating call slides, which are now posted on investor relations website. Our goal has always to be fully transparent to our investors and analysts and over coming quarters we will be revisiting our report metrics and to evaluate, if we can make additions or changes to further that goal. And now, we'll open up the call for questions. Operator?